Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Delta-like Protein 3 (DLL3)- Targeted PET Imaging in Small Cell Lung Cancer

NCT07677787 is registered in ClinicalTrials.gov with The First Affiliated Hospital of Xiamen University as lead sponsor.

NCT NCT07677787
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07677787 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Delta-like Protein 3 (DLL3)- Targeted PET Imaging in Small Cell Lung Cancer
Lead sponsor
The First Affiliated Hospital of Xiamen University
Phase
Not applicable
Overall status
Recruiting
Start date
May 9, 2026
Completion date
May 31, 2028
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

delta-like protein 3, dll3-targeted pet/ct, pet/ct, small cell lung cancer ( sclc )